Abbreviated New Drug Application
May 23, 2012 at 12:21 | Source: Moneycontrol.com
May 07, 2012 at 14:27 | Source: Moneycontrol.com
Apr 25, 2012 at 12:52 | Source: Moneycontrol.com
Apr 09, 2012 at 11:21 | Source: Moneycontrol.com
Mar 07, 2012 at 10:40 | Source: Moneycontrol.com
Mar 01, 2012 at 11:45 | Source: Moneycontrol.com
Interact & exchange stock tips & market info »
Related News »
MIAMI & NEW YORK -- Noven Pharmaceuticals, Inc. today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its lidocaine topical patch 5%. Noven’s ...
May 21, 2012 at 20:47 | Source: Miami Herald
Auxilium and FCB filed this lawsuit in response to a notice letter sent by Watson Laboratories, Inc. (NV) regarding its filing with the FDA of Abbreviated New Drug Application ("ANDA") No. 09‑1073 for a generic 1% testosterone gel product. This letter ...
May 24, 2012 at 11:04 | Source: StreetInsider.com
... announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for butoconazole nitrate 2% vaginal cream. That is the generic equivalent of KV Pharmaceutical Co.’s ...
May 26, 2012 at 10:55 | Source: MLive.com
Watson Pharmaceuticals, Inc. (WPI) recently announced that it has filed an abbreviated new drug application (ANDA) with the U.S. Food and Drug Administration (:FDA) seeking approval to market its generic version of Warner Chilcott’s (WCRX ...
May 23, 2012 at 19:19 | Source: Yahoo Finance
(RTTNews.com) - Watson Pharmaceuticals Inc. (WPI) confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application or ANDA with the U.S. Food and Drug Administration or FDA seeking approval to market ...
May 25, 2012 at 01:23 | Source: NASDAQ
Inc. Under terms of the agreement APP takes complete ownership of the products and becomes the Abbreviated New Drug Application (ANDA) holder for Benztropine Mesylate Injection, Levetiracetam Injection and Tranexamic Acid Injection. "The ...
May 23, 2012 at 12:17 | Source: Marketwatch
for its Abbreviated New Drug Application (ANDA) for Nevirapine tablets USP, 200 mg. This product is the generic version of Boehringer Ingelheim's Viramune and is indicated for combination antiretroviral (ARV) treatment of HIV-1 infection. Mylan CEO Heather ...
May 25, 2012 at 06:02 | Source: pharmabiz.com
Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Testosterone ...
May 25, 2012 at 04:15 | Source: News-Medical.Net
Inc. Under terms of the agreement APP takes complete ownership of these products and becomes the Abbreviated New Drug Application (ANDA) holder. "The addition of these products broadens an already extensive portfolio of injectable APP critical care ...
May 25, 2012 at 02:56 | Source: pharmabiz.com
... Inc. has received final approval from the U.S. Food and Drug Administration or FDA for its Abbreviated New Drug Application or ANDA for Nevirapine Tablets USP, 200 mg. The company said that the product is the generic version of Boehringer ...
May 24, 2012 at 07:29 | Source: NASDAQ